Annual Drug Patent Expirations for ABILIFY+MAINTENA+KIT Abilify Maintena Kit is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier.…
The post New patent for Otsuka Pharm drug ABILIFY MAINTENA KIT appear…
New patent for Otsuka Pharm drug ABILIFY MAINTENA KIT Read Post »
Annual Drug Patent Expirations for TIBSOVO Tibsovo is a drug marketed by Servier and is included in one NDA. There are eight patents protecting this drug. This drug has one…
The post New patent for Servier drug TIBSOVO appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for TIBSOVO Tibsovo is a drug marketed by Servier and is included in one NDA. There are eight patents protecting this drug. This drug has one…
The post New patent for Servier drug TIBSOVO appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for APTIOM Aptiom is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent for Sunovion Pharms drug APTIOM appeared first on DrugPatentWat…
Annual Drug Patent Expirations for APTIOM Aptiom is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent for Sunovion Pharms drug APTIOM appeared first on DrugPatentWat…
Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent expiration for Oncopeptides Ab drug PEPAXTO appeared fi…
New patent expiration for Oncopeptides Ab drug PEPAXTO Read Post »
Annual Drug Patent Expirations for PEPAXTO Pepaxto is a drug marketed by Oncopeptides Ab and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent expiration for Oncopeptides Ab drug PEPAXTO appeared fi…
New patent expiration for Oncopeptides Ab drug PEPAXTO Read Post »
Annual Drug Patent Expirations for GELNIQUE+3%25 Gelnique 3% is a drug marketed by Allergan and is included in one NDA. There is one patent protecting this drug. Drug patent litigation…
The post New patent expiration for Allergan drug GELNIQUE 3% appea…
New patent expiration for Allergan drug GELNIQUE 3% Read Post »
Annual Drug Patent Expirations for ELESTRIN Elestrin is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Mylan Speciality drug ELESTRIN appeared first…
New patent expiration for Mylan Speciality drug ELESTRIN Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical c…
Which pharmaceutical companies have the most SPCs in Italy? Read Post »
Get new actionable insights and updates from BiotechBlog
